Cardiac implanted electronic device-related infective endocarditis: Clinical features, management, and outcomes of 80 consecutive patients

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 8, 2014, Pages 978-985

  Kim, David H ^a   Tate, Jesalyn ^a   Dresen, William F ^a   Papa, Frank C ^a   Bloch, Karen C ^a   Kalams, Spyros A ^a   Ellis, Christopher R ^a   Baker, Michael T ^a   Lenihan, Daniel J ^a   Mendes, Lisa A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

echocardiography; endocarditis; ICD; pacemaker

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CAUSE OF DEATH; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SOCIAL SECURITY DEATH INDEX; STAPHYLOCOCCUS EPIDERMIDIS; TERTIARY CARE CENTER; ADVERSE EFFECTS; ARTIFICIAL HEART PACEMAKER; ENDOCARDITIS, BACTERIAL; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; TREATMENT OUTCOME;

AGED; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84905965595     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12452     Document Type: Article

References (26)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
6. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
7. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter defibrillators in the United States. J Am Coll Cardiol 2011; 58: 1001-1006.
8. Baman TS, Gupta SK, Valle JA, Yamada E,. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2009; 2: 129-134.
9. Darouiche RO,. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429.
10. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Management and outcome of permanent pacemaker and implantable cardioverter defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859.
11. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
12. Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miro JM, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. J Am Med Assoc 2012; 307: 1727-1735.
13. Massoure PL, Reuter S, Lafitte S, Laborderie J, Bordachard P, Clementy J, Roudaut R,. Pacemaker endocarditis: Clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol 2007; 30: 12-19.
14. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
15. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
16. Parsonnet V, Zucker R, Gilbert L, Myers GH,. Clinical use of an implantable standby pacemaker. J Am Med Assoc 1966; 196: 784-786.
17. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
18. Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ,. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 2001; 88: 516-520.
19. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.
20. Zhan C, Baine WB, Sedrakyan A, Steiner C,. Cardiac device implantation in the United States from 1997 through 2004: A population-based analysis. J Gen Intern Med 2008; 23 (Suppl. 1): 13-19.
21. Fowler VG, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28: 106-114.
22. Roig IL, Darouiche RO, Musher DM, Trautner BW,. Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population. Scand J Infect Dis 2012; 44: 753-760.
23. Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, Peacock J, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012; 59: 681-687.
24. Kolek MJ, Dresen WF, Wells QS, Ellis CR,. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol 2013; 36: 354-361.
25. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon A,. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010; 33: 705-711.
26. Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ,. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: A matched cohort study. Clin Infect Dis 2013; 56: 1562-1569.